Abstract:Technological advances and high-throughput bio-chemical assays are rapidly changing ways how we formulate and test biological hypotheses, and how we treat patients. Most complex diseases arise on a background of genetics, lifestyle and environment factors, and manifest themselves as a spectrum of symptoms. To fathom intricate biological processes and their changes from healthy to disease states, we need to systematically integrate and analyze multi-omics datasets, ontologies, and diverse annotations. Without proper management of such complex biological and clinical data, artificial intelligence (AI) algorithms alone cannot be effectively trained, validated, and successfully applied to provide trustworthy and patient-centric diagnosis, prognosis and treatment. Precision medicine requires to use multi-omics approaches effectively, and offers many opportunities for using AI, "big data" analytics, and integrative computational biology workflows. Advances in optical and biochemical assay technologies including sequencing, mass spectrometry and imaging modalities have transformed research by empowering us to simultaneously view all genes expressed, identify proteome-wide changes, and assess interacting partners of each individual protein within a dynamically changing biological system, at an individual cell level. While such views are already having an impact on our understanding of healthy and disease conditions, it remains challenging to extract useful information comprehensively and systematically from individual studies, ensure that signal is separated from noise, develop models, and provide hypotheses for further research. Data remain incomplete and are often poorly connected using fragmented biological networks. In addition, statistical and machine learning models are developed at a cohort level and often not validated at the individual patient level. Combining integrative computational biology and AI has the potential to improve understanding and treatment of diseases by identifying biomarkers and building explainable models characterizing individual patients. From systematic data analysis to more specific diagnostic, prognostic and predictive biomarkers, drug mechanism of action, and patient selection, such analyses influence multiple steps from prevention to disease characterization, and from prognosis to drug discovery. Data mining, machine learning, graph theory and advanced visualization may help identify diagnostic, prognostic and predictive biomarkers, and create causal models of disease. Intertwining computational prediction and modeling with biological experiments leads to faster, more biologically and clinically relevant discoveries. However, computational analysis results and models are going to be only as accurate and useful as correct and comprehensive are the networks, ontologies and datasets used to build them. High quality, curated data portals provide the necessary foundation for translational research. They help to identify better biomarkers, new drugs, precision treatments, and should lead to improved patient outcomes and their quality of life. Intertwining computational prediction and modeling with biological experiments, efficiently and effectively leads to more useful findings faster.

The principle of uncertainty in biology: Will machine learning/artificial intelligence lead to the end of mechanistic studies?

Understanding Biology in the Age of Artificial Intelligence

Machine learning alternative to systems biology should not solely depend on data

Is machine learning good or bad for the natural sciences?

The challenges of purely mechanistic models in biology and the minimum need for a 'mechanism-plus-X' framework

Artificial Intelligence, Chaos, Prediction and Understanding in Science

Artificial Intelligence, Physiological Genomics, and Precision Medicine.

Questions to Guide the Future of Artificial Intelligence Research

Data science and molecular biology: prediction and mechanistic explanation

AI and modern experimental biology: A historical perspective

Biological Robots: Perspectives on an Emerging Interdisciplinary Field

The evolution of systems biology and systems medicine: From mechanistic models to uncertainty quantification

The Automated Laplacean Demon: How ML Challenges Our Views on Prediction and Explanation

Machine learning tools advance biophysics

Exploration, inference and prediction in neuroscience and biomedicine

Biological underpinnings for lifelong learning machines

Are biological systems poised at criticality?

Explainable biology for improved therapies in precision medicine: AI is not enough

Machine Learning in Molecular Dynamics Simulations of Biomolecular Systems

Noise in Biomolecular Systems: Modeling, Analysis, and Control Implications

Machine learning for decision-making under uncertainty